Learn about the current and upcoming legal, regulatory, clinical status of psychedelic-assisted therapies in Canada. Learn how a plan member may seek reimbursement for these therapies from their private benefits plan. Learn about the Canadian Psychedelic Survey (CPS), a comprehensive general population survey of psychedelic use in Canadian adults.

Speakers:
Philippe Lucas, President, SABI Mind Inc.
Johny Ma, President, Mapol Inc.